Compare ELS & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELS | SNN |
|---|---|---|
| Founded | 1992 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Industrial Specialties |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2B | 14.3B |
| IPO Year | 1994 | N/A |
| Metric | ELS | SNN |
|---|---|---|
| Price | $64.01 | $33.49 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 2 |
| Target Price | ★ $70.85 | $36.25 |
| AVG Volume (30 Days) | ★ 1.2M | 659.5K |
| Earning Date | 04-20-2026 | 04-30-2026 |
| Dividend Yield | ★ 3.39% | 2.27% |
| EPS Growth | ★ 2.55 | N/A |
| EPS | ★ 2.01 | N/A |
| Revenue | ★ $1,531,382,000.00 | N/A |
| Revenue This Year | $3.97 | $8.61 |
| Revenue Next Year | $4.69 | $5.60 |
| P/E Ratio | ★ $31.87 | $64.97 |
| Revenue Growth | ★ 0.34 | N/A |
| 52 Week Low | $57.63 | $25.45 |
| 52 Week High | $69.00 | $38.79 |
| Indicator | ELS | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 44.91 | 54.49 |
| Support Level | $58.56 | $32.03 |
| Resistance Level | $68.73 | $33.89 |
| Average True Range (ATR) | 1.00 | 0.54 |
| MACD | 0.10 | 0.23 |
| Stochastic Oscillator | 66.45 | 84.76 |
Equity Lifestyle Properties is a residential REIT that focuses on owning manufactured housing, residential vehicle communities, and marinas. The company currently has a portfolio of 455 properties across the US with a higher concentration in the Sunbelt; 38% of the company's properties are in Florida, 12% in Arizona, and 8% in California. Equity Lifestyle targets owning properties in attractive retirement destinations. More than 70% of the company's properties are either age-restricted or have an average resident age over 55.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.